Start for free
Start for free
Integra Holdings logo

Integra Holdings

Europe, Zurich, Switzerland, Wallisellen

Description

Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions

Investor Profile

Integra Holdings has made 8 investments, with 0 in the past 12 months and 75% as lead.

Stage Focus

  • Seed (75%)
  • Series F (13%)
  • Series B (13%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Health Care
  • Medical
  • Clinical Trials
  • Therapeutics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Integra Holdings frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Israel Biotech Fund
Israel Biotech Fund
Asia, HaMerkaz, Israel, Rehovot
Co-Investments: 1
Lundbeckfonden Ventures
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Asahi Kasei
Asahi Kasei
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Arix Bioscience
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 1
SR One
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
B
Co-Investments: 1
Adams Street Partners
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
TB
The Becker Group
North America, Maryland, United States, Baltimore
Co-Investments: 1
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
North America, Maryland, United States, Bethesda
Co-Investments: 1

What are some of recent deals done by Integra Holdings?

Splisense

Jerusalem, Yerushalayim, Israel

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.

BiotechnologyLife SciencePharmaceutical
Series BMay 13, 2021
Amount Raised: $28,500,000
BacoCure

Jerusalem, Yerushalayim, Israel

BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.

BiotechnologyHealth CareLife SciencePharmaceutical
SeedJan 1, 2018
Rebiotic Rx

Jerusalem, Yerushalayim, Israel

Rebiotic Rx is develops novel liposomal antibiotics for antibiotic-resistant bacterial infections.

BiotechnologyHealth CareLife SciencePharmaceutical
SeedJan 1, 2018
Atox Bio

Ness Ziona, HaMerkaz, Israel

Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.

BiotechnologyClinical TrialsTherapeutics
Series FDec 4, 2017
Amount Raised: $30,000,000
Nectin Therapeutics

Jerusalem, Yerushalayim, Israel

Nectin Therapeutics is a startup company dedicated to the development of next generation immuno-oncology antibodies.

BiotechnologyLife ScienceOncology
SeedJan 1, 2017
Splisense

Jerusalem, Yerushalayim, Israel

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.

BiotechnologyLife SciencePharmaceutical
SeedJan 1, 2016
NeoProl

Jerusalem, Yerushalayim, Israel

NeoProl develops medical formulations designed to the preparation of anesthesia drugs.

Health CareMedicalPharmaceutical
SeedJan 1, 2014
Ophrx

Tel Aviv, Tel Aviv, Israel

Ophrx is developing novel drug products for topical administration for diseases involving front-of the eye and back of the eye compartments.

MedicalPharmaceutical
SeedJan 1, 2014
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator